Litcius/Paper detail

Intrauterine administration of autologous hCG- activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; A double-blind, randomized control trial study

Zahra Pourmoghadam, Mohammad Sadegh Soltani‐Zangbar, Golshan Sheikhansari, Ramyar Azizi, Shadi Eghbal‐Fard, Hamed Mohammadi, Homayoon Siahmansouri, Leili Aghebati‐Maleki, Shahla Danaii, Amir Mehdizadeh, Mohammad Hojjat‐Farsangi, Roza Motavalli, Mehdi Yousefi

2020Journal of Reproductive Immunology49 citationsDOI

Topics & Concepts

MedicinePeripheral blood mononuclear cellMiscarriagePregnancyLive birthRandomized controlled trialImplantation failureFlow cytometryPregnancy rateInternal medicineGastroenterologyAndrologyImmunologyInfertilityIn vitroChemistryGeneticsBiologyBiochemistryReproductive System and PregnancyEndometriosis Research and TreatmentEctopic Pregnancy Diagnosis and Management
Intrauterine administration of autologous hCG- activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; A double-blind, randomized control trial study | Litcius